TRIM25 stabilized H3K27me3 methyltransferase EZH2 by blocking TRAF6-mediated ubiquitination for EZH2 degradation, thus maintaining the stem-like properties for an enhanced oxaliplatin resistance in CRC [13]. This evidence concerns the gene EZH2 and colorectal carcinoma.